Get the app
US › Financial Services

Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)

US · Financial Services · Shell Companies

$10.870.00%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$0
Net profit
$1.7M
Profit YoY
-24.5%
EPS
$0.06

Key statistics

Market cap
$263.9M
P/E
60.4
Forward P/E
0.0
P/B
1.91
Book value
$-0.30
EPS (TTM)
$0.18
52-week high
$10.89
52-week low
$10.29
50-day MA
$10.80
200-day MA
$10.61

Shareholding

Insiders
23.57%
Institutions
53.43%

Largest institutional holders

FundStake
Mizuho Securities USA Inc16.76%
Karpus Management Inc10.33%
Polar Asset Management Partners4.72%
Glazer Capital, LLC4.12%
Wolverine Asset Management LLC3.43%
Highbridge Capital Management, LLC3.33%
First Trust Capital Management L.P.3.24%
Heights Capital Management Inc2.67%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Drugs Made In America Acquisition Corp. Ordinary Shares — free to start.

Open in the appGoogle PlayApp Store

Other Financial Services companies

Berkshire Hathaway IncBerkshire Hathaway IncJPMorgan Chase & CoVisa Inc. Class AMastercard IncBank of America CorpHSBC Holdings PLC ADRMorgan StanleyRoyal Bank of CanadaGoldman Sachs Group IncWells Fargo & CompanyMitsubishi UFJ Financial Group Inc ADR

Data updated 2026-10-19.